SCHEMBL28503671

SCHEMBL28503671

CNC1CC(n2cc(C#N)c3ccc(N4CCN(c5ccc(C(=O)O)cc5)CC4)nc32)C1

nearest known ligand 0.39

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ USP2 O75604 1/20 0.37
▸ CHEK1 O14757 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21268737 0.93 MAPT (0.39) —
SCHEMBL21281509 0.93 MAPT (0.39) —
SCHEMBL21268734 0.93 MAPT (0.39) —
SCHEMBL21274025 0.91 KMT2A (0.41) —
SCHEMBL21274023 0.91 KMT2A (0.41) —
SCHEMBL21273967 0.90 TBK1 (0.33) —
SCHEMBL21274262 0.90 MAPT (0.32) —
SCHEMBL21274379 0.90 CHRNA10 (0.37) —
SCHEMBL21274264 0.90 MAPT (0.32) —
SCHEMBL21274295 0.90 CDK8 (0.42) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112105357-A Pharmaceutically acceptable 6,5 heterobicyclic derivatives UCB生物制药有限责任公司 2020-12-18 — — CN claimed
CN-112105357-A Pharmaceutically acceptable 6,5 heterobicyclic derivatives UCB生物制药有限责任公司 2020-12-18 — — CN disclosed
Send feedback